NHS Innovation Ecosystem – Commercial Entry Points

The NHS remains one of the most influential - and complex - healthcare systems in the world. For innovators and life sciences companies seeking to enter or expand within the UK market, the opportunity is significant, but the pathways are rarely straightforward. Unlike fragmented systems elsewhere, the NHS operates through interconnected regional bodies, innovation networks, procurement frameworks, and evolving policy priorities that shape how new solutions are evaluated, adopted, and scaled.

Understanding the NHS innovation ecosystem requires more than familiarity with procurement rules - it demands insight into where influence sits, how clinical and commercial priorities align, and which partnerships accelerate adoption versus stall progress. As integrated care systems mature and national innovation bodies refine their mandates, the question is no longer whether innovation is welcomed, but how to navigate the system effectively and sustainably.

This roundtable brings together leaders from Imperial College Health Partners and across the ecosystem to unpack how commercial organisations can engage the NHS strategically - identifying realistic entry points, aligning with system priorities, and building partnerships that deliver measurable value.

Join us to discuss:

Where are the most effective commercial entry points within today’s NHS innovation landscape?

How are integrated care systems and regional innovation hubs influencing adoption decisions?

What distinguishes companies that successfully scale within the NHS from those that remain in pilot mode?